Processa Pharmaceuticals, Inc. (PCSA)
Nasdaq: PCSA · CIK 0001533743 · United States
Every official Processa Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PCSA filings
Processa Pharmaceuticals, Inc. documents
- Processa Pharmaceuticals, Inc. 10-K 2026PCSA 10-K 2026: annual report for fiscal 2026
- Processa Pharmaceuticals, Inc. 10-K 2025PCSA 10-K 2025: annual report for fiscal 2025
- Processa Pharmaceuticals, Inc. 10-K 2024PCSA 10-K 2024: annual report for fiscal 2024
- Processa Pharmaceuticals, Inc. 10-K 2023PCSA 10-K 2023: annual report for fiscal 2023
- Processa Pharmaceuticals, Inc. 10-K 2022PCSA 10-K 2022: annual report for fiscal 2022
- Processa Pharmaceuticals, Inc. 10-Q 2026PCSA 10-Q 2026: quarterly report for fiscal 2026
- Processa Pharmaceuticals, Inc. 10-Q 2025PCSA 10-Q 2025: quarterly report for fiscal 2025
- Processa Pharmaceuticals, Inc. 10-Q 2024PCSA 10-Q 2024: quarterly report for fiscal 2024
- Processa Pharmaceuticals, Inc. 10-Q 2023PCSA 10-Q 2023: quarterly report for fiscal 2023
- Processa Pharmaceuticals, Inc. 10-Q 2022PCSA 10-Q 2022: quarterly report for fiscal 2022
- Processa Pharmaceuticals, Inc. 8-K 2026PCSA 8-K 2026: current report for fiscal 2026
- Processa Pharmaceuticals, Inc. 8-K 2025PCSA 8-K 2025: current report for fiscal 2025
- Processa Pharmaceuticals, Inc. 8-K 2024PCSA 8-K 2024: current report for fiscal 2024
- Processa Pharmaceuticals, Inc. 8-K 2023PCSA 8-K 2023: current report for fiscal 2023
- Processa Pharmaceuticals, Inc. 8-K 2022PCSA 8-K 2022: current report for fiscal 2022
- Processa Pharmaceuticals, Inc. DEF 14A 2026PCSA DEF 14A 2026: proxy statement for fiscal 2026
- Processa Pharmaceuticals, Inc. DEF 14A 2025PCSA DEF 14A 2025: proxy statement for fiscal 2025
- Processa Pharmaceuticals, Inc. DEF 14A 2024PCSA DEF 14A 2024: proxy statement for fiscal 2024
- Processa Pharmaceuticals, Inc. DEF 14A 2023PCSA DEF 14A 2023: proxy statement for fiscal 2023
- Processa Pharmaceuticals, Inc. DEF 14A 2022PCSA DEF 14A 2022: proxy statement for fiscal 2022
- Processa Pharmaceuticals, Inc. Form 4 2026PCSA Form 4 2026: insider trading filing for fiscal 2026
- Processa Pharmaceuticals, Inc. Form 4 2025PCSA Form 4 2025: insider trading filing for fiscal 2025
- Processa Pharmaceuticals, Inc. Form 4 2024PCSA Form 4 2024: insider trading filing for fiscal 2024
- Processa Pharmaceuticals, Inc. Form 4 2023PCSA Form 4 2023: insider trading filing for fiscal 2023
- Processa Pharmaceuticals, Inc. Form 4 2022PCSA Form 4 2022: insider trading filing for fiscal 2022
- Processa Pharmaceuticals, Inc. S-1 2026PCSA S-1 2026: registration statement for fiscal 2026
- Processa Pharmaceuticals, Inc. S-1 2025PCSA S-1 2025: registration statement for fiscal 2025
- Processa Pharmaceuticals, Inc. S-1 2024PCSA S-1 2024: registration statement for fiscal 2024
- Processa Pharmaceuticals, Inc. S-1 2023PCSA S-1 2023: registration statement for fiscal 2023
- Processa Pharmaceuticals, Inc. S-1 2022PCSA S-1 2022: registration statement for fiscal 2022
- Processa Pharmaceuticals, Inc. 13F 2026PCSA 13F 2026: institutional holdings for fiscal 2026
- Processa Pharmaceuticals, Inc. 13F 2025PCSA 13F 2025: institutional holdings for fiscal 2025
- Processa Pharmaceuticals, Inc. 13F 2024PCSA 13F 2024: institutional holdings for fiscal 2024
- Processa Pharmaceuticals, Inc. 13F 2023PCSA 13F 2023: institutional holdings for fiscal 2023
- Processa Pharmaceuticals, Inc. 13F 2022PCSA 13F 2022: institutional holdings for fiscal 2022
More companies